Picture of Zeria Pharmaceutical logo

4559 — Zeria Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Table: Zeria Pharm - 6-MTH group results

Nov 5 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             39.96               42.42            90.00    
                 (-5.8 pct)          (+15.7 pct)      (+3.1 pct)  
  Operating          3.64                6.46            12.00    
                 (-43.6 pct)         (+21.2 pct)      (-1.6 pct)  
  Recurring          2.66                7.95            12.00    
                 (-66.6 pct)         (+44.6 pct)      (-6.5 pct)  
  Net                1.74                6.06             9.50    
                 (-71.3 pct)         (+12.3 pct)      (-4.4 pct)  
  EPS             39.42 yen          137.51 yen       215.52 yen  
  Ann Div                             47.00 yen        48.00 yen  
  -Q2 div         24.00 yen           23.00 yen                   
  -Q4 div                             24.00 yen        24.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T

Recent news on Zeria Pharmaceutical

See all news